Tested on human blood in the lab, the selective
nanocapsules could reduce the side effects of a major blood clot
dissolving drug, which include bleeding on the brain. If confirmed
with animal tests, the nanocapsules could also make the drug more
effective at lower doses.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
